aestheticmedguideAestheticMedGuide
Devices

At-Home Aesthetic Devices: What 384 FDA Clearances Reveal About the Boom

384 FDA clearances for at-home IPL, LED, and RF devices show a category exploding to 71 in 2025, with Shenzhen maker Ulike now dominating and real injury reports surfacing.

Ran Chen
Ran Chen
8 min read · Published · Evidence-based

The at-home aesthetic device — the handheld IPL hair-removal wand, the LED face mask, the home radiofrequency gadget — has gone from a niche mail-order product to a countertop appliance in roughly fifteen years. The short answer to what the regulatory data shows: the FDA has cleared 384 over-the-counter (OTC) light- and radiofrequency-based aesthetic devices for home use, clearances exploded from roughly 7 per year in the early 2010s to 71 in 2025, a small group of manufacturers led by Shenzhen-based companies (Ulike, Kaiyan) now produce most of them, and a real — if small — stream of injury reports has begun appearing in the FDA's adverse-event database, including a 2025 report attributing a death to a home hair-removal device.

This article walks through an analysis of FDA 510(k) clearance records for OTC aesthetic devices, what "FDA-cleared" actually means for a home gadget, the safety signals now surfacing, and what to look for before buying one. It is educational, not a diagnosis. Burns, blistering, spreading pigmentation, or eye discomfort during or after using a home device should be evaluated by a clinician.

What these devices are

The FDA regulates at-home aesthetic light and radiofrequency devices under a specific set of over-the-counter product codes, each tied to a claimed use:

  • OHT — over-the-counter light-based hair removal (162 clearances). Almost all are intense pulsed light (IPL) handpieces; a few are diode lasers. This is by far the largest category.
  • OHS — over-the-counter light-based wrinkle reduction (150 clearances). LED panels and masks emitting red and near-infrared light.
  • OLP — over-the-counter light-based acne treatment (51 clearances). Blue and blue-red LED devices.
  • PAY — over-the-counter radiofrequency device for aesthetic use (12 clearances). Home RF "skin-tightening" wands.
  • OUP and related OTC codes (9 clearances). A small tail of additional over-the-counter light- and energy-based clearances that round out the category.

Together these 384 clearances describe an entire consumer hardware category that did not meaningfully exist before 2010.

The clearance explosion

Year band Clearances
2006–2011 ~15
2012–2016 ~53
2017–2019 ~54
2020–2021 ~31
2022–2024 143
2025 (single year) 71
2026 (partial) 19

The inflection is unmistakable. Through the mid-2010s, the FDA cleared a handful of these devices each year. Beginning around 2021 — as direct-to-consumer social-media marketing for at-home devices scaled — clearances roughly tripled, and 2025 alone produced more clearances (71) than the entire period from 2006 through 2016. The category is not maturing; it is still accelerating.

Who is making them: the Shenzhen concentration

Clearances concentrate in a small number of applicants, and the geography tells its own story:

Applicant Clearances
Shenzhen Ulike Smart Electronics (China) 21
Shenzhen Kaiyan Medical Equipment (China) 20
Cyden Limited (UK — SmoothSkin) 15
LED Technologies (US) 12
El Global Trade 9
Light Tree Ventures Europe 8
LED Intellectual Properties 7
Foreo (Switzerland) 7
Home Skinovations / Silk'n 7

Two patterns stand out. First, Chinese manufacturers — led by Shenzhen Ulike and Shenzhen Kaiyan — now file the most home-aesthetic-device clearances of any applicants in the FDA database. Ulike in particular has built a large share of the U.S. IPL market on a foundation of repeated 510(k) clearances for successive device generations. Second, the established incumbents — Cyden (SmoothSkin), Home Skinovations (Silk'n, which was the first pulsed-light home hair-removal device cleared by the FDA), and Foreo — have been joined and overtaken by a wave of newer, high-volume filers.

What "FDA-cleared" actually means here

A consumer "FDA-cleared" label carries less weight than most buyers assume. Home aesthetic devices reach the U.S. market through the 510(k) pathway, which clears a device as substantially equivalent to an already-marketed "predicate" device — it is not the same as the rigorous approval process applied to new drugs or higher-risk Class III devices. Several practical consequences follow:

  • The claim is "permanent hair reduction," not removal. The FDA's framework for these devices allows a claim of sustained reduction in hair growth, not permanent elimination of all hair. Maintenance sessions are expected.
  • Home devices are deliberately lower-energy than in-office lasers. That is the safety trade-off for untrained, at-home use: less energy means less efficacy per session and a longer treatment course, but also a lower ceiling on acute injury when used as directed.
  • Skin-tone fit is built into the clearance, not guaranteed by it. Many IPL home devices are cleared only for lighter skin tones because the device's light targets melanin, and darker skin carries a higher risk of post-inflammatory hyperpigmentation (PIH) and burns. A handful (notably devices combining IPL with radiofrequency) have been cleared for broader skin-tone ranges.

The safety signals now surfacing

Because these devices are used by untrained consumers in unsupervised settings, the FDA's MAUDE database is starting to capture what goes wrong. Two 2025 reports are representative of the emerging signal:

  • A home laser hair-removal device manufactured by Shenzhen Ionka Medical Technology (product code OHT), with the outcome attributed to the adverse event recorded as death and required intervention (FDA received June 2025).
  • An Innza IPL hair-removal device manufactured by Foshan Jindi Electric Appliance (OHT), with outcomes recorded as life-threatening, hospitalization, and disability (FDA received October 2025).

The standard MAUDE caveats apply in full: these are passive reports, a report records an event that followed use rather than proof the device caused it, and underreporting is substantial. A death report does not mean a handheld IPL device killed someone — it means the event was reported in association with the device and is under FDA review. But the appearance of serious-outcome reports in this category is itself notable for a product class marketed as inherently safe for home use. The more common, well-documented injuries from home IPL are burns and post-inflammatory hyperpigmentation from excessive passes or use on too-dark skin or over tattoos, where the light can interact with ink.

Skin-of-color and at-home devices

The blog's standing rule on Fitzpatrick IV–VI safety applies sharply here. Home IPL devices are riskiest on darker skin because melanin in the epidermis absorbs the same light aimed at the hair follicle, producing heat in the skin itself. Practical implications:

  • Check the device's cleared skin-tone range before buying — many IPL handpieces explicitly exclude darker skin or require the built-in skin sensor to fire.
  • Home diode lasers (e.g., 808 nm / 980 nm) are generally safer across a wider skin-tone range than broadband IPL, mirroring the in-office principle that longer wavelengths protect epidermal melanin.
  • Do not use any home light-based hair-removal device over a tattoo; the light can alter ink and burn the skin over it.
  • Anyone with melasma, a recent tan, or a history of PIH should treat home IPL with caution and prefer a clinic-based device chosen for their skin type.

Dermatologists consistently recommend a patch test before a full session — treat a small area and wait 24 to 48 hours; stop entirely if the skin blisters or burns. The most common pathway to a home-device injury is not the device itself but too many passes, the wrong skin tone, or use over a tattoo, where the light can interact with ink.

What to look for before buying

  • A real 510(k) number, not just "FDA-cleared" marketing. The clearance should be verifiable in the FDA's 510(k) database for the specific model.
  • The cleared skin-tone and hair-color range. If a device is cleared only for light skin with dark hair, that is who it was studied on.
  • Eye safety. Most cleared home devices are designed so the light is contained within the handpiece and do not require separate eyewear, but this is worth confirming for the specific model.
  • A realistic expectation of sessions. Home devices require weeks of consistent use to produce visible reduction, and ongoing maintenance.

The at-home device boom is real, and the clearance data shows it is accelerating and globalizing — increasingly led by high-volume Shenzhen manufacturers. The devices can work, within the limits of lower energy and "reduction" rather than "removal." The same data, and the early injury reports, are a reminder that "FDA-cleared" for a consumer gadget is a lower bar than most buyers believe, and that the skin in front of the device is still the patient's own.

Sources

Ran Chen
Contributing Editor
Ran Chen

Founder, AestheticMedGuide. Life-sciences operator covering aesthetic devices, injectables, and the industry behind them. Previously global market-access lead across pharma and medtech.

Follow on LinkedIn →